Navigation Links
Research-Based Biopharmaceutical Company Awards Trials to DATATRAK
Date:8/25/2009

CLEVELAND, Aug. 25 /PRNewswire-FirstCall/ -- DATATRAK International, Inc.(OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of two new studies with a global research-based biopharmaceutical company. The award includes a multi-site, five-year study and demonstrates a long-term commitment to the DATATRAK eClinical(TM) platform.

"We are pleased that our partnership with this biopharmaceutical continues to grow," said Laurence Birch, DATATRAK's Chairman of the Board. "The signing of new business with existing clients validates our technology and service delivery model, DATATRAK ONE(TM). Our Enterprise Transfer clients are able to successfully develop and deliver trials utilizing DATATRAK's technology and online resources."

DATATRAK eClinical(TM) empowers clinical users and service providers with the tools necessary for efficiently conducting, delivering and managing clinical trials. Built upon a unified architecture, eClinical's Clinical Suite, Trial Manager, Enterprise Manager and Enterprise Platform components provide the foundation for end-to-end Clinical Trial Solutions. Whether deploying products via DATATRAK's Enterprise Transfer program or relying on the DATATRAK team for project delivery as a Software as a Service (SaaS) client, DATATRAK provides the most complete product and service offering for the Clinical Trial Life Cycle.

About DATATRAK International, Inc.

DATATRAK International, Inc. is a worldwide technology company focused on the provision of multi-component eClinical solutions and related services for the clinical trials industry. We operate under the concept of DATATRAK ONE(TM), which encompasses our unique, single platform technology. The singular architecture of our DATATRAK eClinical(TM) product suite has been embraced by clients around the globe for its ability to ef
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
2. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
3. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
4. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
5. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
6. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
7. XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma
8. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
9. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
10. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
11. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... N.J. and FARMINGTON, Conn. ... Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company ... of diseases with significant unmet medical need and ... on a private placement of 2,050,000 shares of ... purchase 24,949,325 shares of its common stock.  Funds ...
(Date:12/24/2014)... , Dec. 23, 2014 PuraMed BioScience®, Inc., ... over-the-counter (OTC) medicinal and healthcare products, announced it received ... H, a hemp-based, advanced headache relief product, for planned ... Colorado , Washington State ... With the MigraPure H Advanced headache relief gel ...
(Date:12/24/2014)... , Dec. 23, 2014  Advanced Medical Isotope ... engaged primarily in the development of brachytherapy devices ... today announced that it has filed a ... Drug Administration ("FDA") for marketing clearance for its ... of the U.S. Food, Drug and Cosmetic Act ...
Breaking Medicine Technology:Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
... 28, 2011 Auxilium Pharmaceuticals, Inc. (Nasdaq: ... in the Oppenheimer 22nd Annual Healthcare Conference during December ... City.  Mr. James Fickenscher, Auxilium,s Chief Financial Officer, is ... its product pipeline at 10:15 am ET on Tuesday, ...
... (NYSE: SHP ) ("ShangPharma" or the "Company"), ... outsourcing company, today announced that it is scheduled to ... Ms. Lan Xie, Vice President of Finance ... following conferences: Deutsche Bank 5th Annual MedTools ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference 2Auxilium Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference 3ShangPharma to Attend Two Upcoming Investor Conferences 2
(Date:12/26/2014)... London, England (PRWEB) December 26, 2014 ... to take place March 24-28, 2015 in Rome, Italy ... years' line-up includes workshops on a wide ... insomnia, as well as peak performance training in athletes. ... from around the world. , Biofeedback monitoring allows clients ...
(Date:12/26/2014)... Pentec Health, Inc. number fourteen on the ... for 2014. The awards program, created in 2000, is ... in the country. The program is a public/private partnership ... and Economic Development, the Pennsylvania State Council of the ... Business Journal. , Charlie Wilson, Vice President ...
(Date:12/25/2014)... 26, 2014 This is a professional ... global Sterilizers industry with a focus on the Chinese ... status of the Sterilizers manufacturers and is a valuable ... interested in the industry. This report provides a basic ... manufacturing technology. In this part, the report presents the ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) ... LLP reports. According to an Order issued in the ... 20th, the Court will convene an open conference on ... Building and United States Courthouse in West Palm Beach, ...
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3
... The Quantum Group,Inc. (Amex: QGP ), a ... J. Guillama, President & Chief Executive Officer,will be ... November 12, 2008. Mr. Guillama will be joined ... & Innovations Officer,and Ron Smith, Senior Vice President ...
... Calif., Nov. 4 CorVel Corporation,(Nasdaq: CRVL ) reported ... 2008, compared to $0.40 in the same quarter of the ... were $0.75 per,share compared to the same period in the ... quarterly revenues of $78 million, up from prior,year quarterly revenues ...
... PCAS has,launched its new internet site, dedicated to ... provides detailed information on PCAS, two main fields ... It focuses on R&D capability as well as ... What is more, the site demonstrates PCAS, expertise ...
... more customers are trying to economize by choosing cheaper shipping methods ... ... Medisave ( www.medisave.net ), a leading global medical equipment ... and Australia, today announced that despite the global credit crunch, global ...
... Institute of Allergy and Infectious Diseases (NIAID) scientist Theodore ... seizures with areas of brain tissue swelling in people ... edemas, form around dead, calcified cysts that result when ... the brain. The illness caused by T. solium ...
... NOVEMBER 20, 2008, JUPITER, Fla., Nov. 3 From November ... State to promote,National Smoke Out Day, November 20, and to promote ... habit., -- MISS AMERICA 2008 KIRSTEN HAGLUND, WILL ... INTERVIEWS FROM NOVEMBER 15-17 TO PROMOTE SAVING LIVES, AND ...
Cached Medicine News:Health News:The Quantum Group Inc. To Present at Paulson Investment's 31st Annual Westergaard Conference 2Health News:The Quantum Group Inc. To Present at Paulson Investment's 31st Annual Westergaard Conference 3Health News:CorVel Announces Second Quarter Revenues and Earnings 2Health News:CorVel Announces Second Quarter Revenues and Earnings 3Health News:CorVel Announces Second Quarter Revenues and Earnings 4Health News:Despite Credit Crunch, Medisave Sees Strong Sales Increase in 2008 2Health News:Despite Credit Crunch, Medisave Sees Strong Sales Increase in 2008 3
Nucleus Hydrodissection Cannula, 25 g. Angled with flattened tip. 7 mm angled shaft with flattened tip for insertion under the capsular flap. Overall length 19 mm. 5/box....
Posterior Capsule Polisher, 21 g. Roughened tip, top port. Overall length 23 mm. 5/box....
Irrigating Cystotome, Straight, 25 g. Overall length 15 mm. 5/box....
Irrigating Cystotome, formed, 25 g., 12 mm curved tip. Overall length 14 mm. 5/box....
Medicine Products: